Aperam S.A.
APEMY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,007,353 | $2,025,607 | $2,234,536 | $1,831,103 |
| - Cash | $376,000 | $239,000 | $185,000 | $216,000 |
| + Debt | $1,603,875 | $1,622,261 | $1,420,000 | $760,000 |
| Enterprise Value | $3,235,228 | $3,408,868 | $3,469,536 | $2,375,103 |
| Revenue | $1,647,653 | $1,654,000 | $1,658,000 | $1,471,000 |
| % Growth | -0.4% | -0.2% | 12.7% | – |
| Gross Profit | $1,410,000 | $1,654,000 | $1,658,000 | $1,471,000 |
| % Margin | 85.6% | 100% | 100% | 100% |
| EBITDA | $86,473 | $112,000 | $50,000 | $118,000 |
| % Margin | 5.2% | 6.8% | 3% | 8% |
| Net Income | -$24,540 | $19,000 | -$18,000 | $12,000 |
| % Margin | -1.5% | 1.1% | -1.1% | 0.8% |
| EPS Diluted | -0.34 | 0.25 | -0.25 | 0.16 |
| % Growth | -236% | 200% | -256.3% | – |
| Operating Cash Flow | $191,764 | $196,000 | -$105,000 | $172,000 |
| Capital Expenditures | -$20,182 | -$39,000 | -$54,000 | -$27,000 |
| Free Cash Flow | $171,582 | $157,000 | -$159,000 | $145,000 |